Clinical Trials Browser

Phase 3 × Has announcements × Leuprolide × Clear all

NCT02319837 2025-07-08

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

Phase 3 Active not recruiting

1,068 enrolled 20 charts 1 FDA

Prostatic Neoplasms

NCT03085095 2022-01-18

HERO

Phase 3 Completed

1,134 enrolled 38 charts 2 FDA

Prostatic Neoplasms